DMH1 TGF-beta/Smad inhibitor

Cat.No.S7146

DMH1 is a selective BMP receptor inhibitor with IC50 of 107.9 nM for ALK2, exhibiting no inhibition on AMPK, ALK5, KDR (VEGFR-2) or PDGFR. This compound inhibits autophagy.
DMH1 TGF-beta/Smad inhibitor Chemical Structure

Chemical Structure

Molecular Weight: 380.44

Quality Control

Cell Culture, Treatment & Working Concentration

Cell Lines Assay Type Concentration Incubation Time Formulation Activity Description PMID
A549 Function assay 3 and 5 µM 24 h DMH1 treatment effectively blocked Smad 1/5/8 phosphorylation in a dose dependent manner 24603907
SKOV3 Function assay 20 μM 24 h reduce the canonical phosphorylation of Smads 1,5 and 9 26235139
OVCAR8 Function assay 20 μM 24 h reduce the canonical phosphorylation of Smads 1,5 and 9 26235139
OVCAR3 Function assay 20 μM 24 h reduce the canonical phosphorylation of Smads 1,5 and 9 26235139
MCF-7 Function assay 5 μmol/L and 10 μmol/L 24 h completely abolished the increase of autophagy responses in MCF-7 cells 26579463
HeLa Function assay 5 μmol/L and 10 μmol/L 24 h DMH1 inhibited CDDP-induced autophagy in HeLa cells. 26579463
HUVECs Function assay 4.5 μM 2 h simultaneous stimulation of BMPER and BMP4 together with DMH1 prevented augmentation of NICD and HES1 on the protein level 29473997
Click to View More Cell Line Experimental Data

Chemical Information, Storage & Stability

Molecular Weight 380.44 Formula

C24 H20 N4 O

Storage (From the date of receipt)
CAS No. 1206711-16-1 Download SDF Storage of Stock Solutions

Synonyms N/A Smiles CC(C)OC1=CC=C(C=C1)C2=CN3C(=C(C=N3)C4=CC=NC5=CC=CC=C45)N=C2

Solubility

In vitro
Batch:

DMSO : 25 mg/mL ( (65.71 mM) Moisture-absorbing DMSO reduces solubility. Please use fresh DMSO.)

Water : Insoluble

Ethanol : Insoluble

Molarity Calculator

Mass Concentration Volume Molecular Weight

In vivo
Batch:

In vivo Formulation Calculator (Clear solution)

Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)

mg/kg g μL

Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO % % Tween 80 % ddH2O
%DMSO %

Calculation results:

Working concentration: mg/ml;

Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )

Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.

Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.

Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such
as vortex, ultrasound or hot water bath can be used to aid dissolving.

Mechanism of Action

Targets/IC50/Ki
ALK2 [1]
(Cell-free assay)
107.9 nM
In vitro
DMH1 inhibits BMP signaling with IC50 of 100 nM, and selectively inhibits the BMP-induced Smad1/5/8 activation. [1] This compound increases cardiomyocyte progenitors and promotes cardiac differentiation in mouse embryonic stem cells. [3] In addition, as a BMP inhibitor, it significantly reduces NSCLC cell growth, migration and invasion. [4]
Kinase Assay
Kinase assay
All kinase assays are conducted by Reaction Biology Corp. In brief, this compound is tested at 10 concentrations by 3-fold serial dilutions starting at 30 μM, using nonspecific kinase inhibitor staurosporine as control. In vitro kinase reactions are carried out in the presence of 10 μM (33P)γATP. Five kinases tested are the human BMP type-I receptor activin receptor-like kinase 2 (ALK-2/ACVR1), the human TGFβ type-I receptor activin receptor-like kinase 5 (Alk5/TGFβR1), the human VEGF type-II receptor (KDR/Flk-1/VEGFR2), the human AMP-activated protein kinase (AMPK/A1/B1/G1) and the human platelet-derived growth factor receptor-β (PDGFRβ).
In vivo
DMH1 dorsalizes the embryonic axis without disrupting the angiogenic process in Zebrafish embryos. [1] In proepicardial explants, this compound results in the greatest inhibition of epithelial sheet migration. [2] This chemical (5 mg/kg i.p.) attenuates xenograft lung tumor growth in mice bearing A549 xenograft. [4]
References

Applications

Methods Biomarkers Images PMID
Western blot Integrin β1 / p-Smad / Smad1 / p-AKT / AKT S7146-WB1 26337467
Growth inhibition assay Cell proliferation S7146-viability1 26337467

Tech Support

Handling Instructions

Tel: +1-832-582-8158 Ext:3

If you have any other enquiries, please leave a message.

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.

Signaling Pathway Map